Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma*
暂无分享,去创建一个
Christoph H Borchers | Darryl B. Hardie | Juncong Yang | N Leigh Anderson | Angela M Jackson | C. Borchers | M. Kuzyk | D. Hardie | Juncong Yang | Derek Smith | A. Jackson | Derek Smith | Michael A Kuzyk | Darryl B Hardie | Tyra J Cross | N. L. Anderson | N. Leigh Anderson | Tyra J. Cross | Tyra Cross
[1] Robertson Craig,et al. Open source system for analyzing, validating, and storing protein identification data. , 2004, Journal of proteome research.
[2] W. Demark-Wahnefried,et al. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] R. Cooks,et al. Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures , 1978 .
[4] Kym Faull,et al. Characterization of serum biomarkers for detection of early stage ovarian cancer , 2005, Proteomics.
[5] J. Griffiths,et al. Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity *S , 2005, Molecular & Cellular Proteomics.
[6] Werner Zolg,et al. Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards , 2004, Proteomics.
[7] Tetsuya Terasaki,et al. Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria , 2008, Pharmaceutical Research.
[8] R. Plumb,et al. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[9] N. Anderson,et al. A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.
[10] E. Duchoslav,et al. Multiple reaction monitoring as a method for identifying protein posttranslational modifications. , 2005, Journal of biomolecular techniques : JBT.
[11] Robertson Craig,et al. The use of proteotypic peptide libraries for protein identification. , 2005, Rapid communications in mass spectrometry : RCM.
[12] Chun-Ta Liao,et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. , 2005, Clinical chemistry.
[13] M. Mann,et al. Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.
[14] Leigh Anderson,et al. Candidate‐based proteomics in the search for biomarkers of cardiovascular disease , 2005, The Journal of physiology.
[15] Kelvin H. Lee,et al. Quantitative analysis of protein expression using amine‐specific isobaric tags in Escherichia coli cells expressing rhsA elements , 2005, Proteomics.
[16] Irina Kusmartseva,et al. Panel of serum biomarkers for the diagnosis of lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[18] A. Stieg,et al. Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer. , 2003, Urology.
[19] Henry H. N. Lam,et al. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows , 2008, EMBO reports.
[20] J. Green,et al. Peer Reviewed: A Practical Guide to Analytical Method Validation , 1996 .
[21] Mu Wang,et al. A multiple reaction monitoring method for absolute quantification of the human liver alcohol dehydrogenase ADH1C1 isoenzyme. , 2007, Analytical biochemistry.
[22] S. Ha,et al. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease , 2007, BMC neurology.
[23] K Kronkvist,et al. Automated sample preparation for the determination of budesonide in plasma samples by liquid chromatography and tandem mass spectrometry. , 1998, Journal of chromatography. A.
[24] Matthias Mann,et al. Mass spectrometric-based approaches in quantitative proteomics. , 2003, Methods.
[25] S. Carr,et al. Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.
[26] N Leigh Anderson,et al. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. , 2008, Clinical chemistry.
[27] Jinxiang Han,et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients , 2008, BMC Cancer.
[28] Bindu Nanduri,et al. Prediction of peptides observable by mass spectrometry applied at the experimental set level , 2007, BMC Bioinformatics.
[29] Leigh Anderson,et al. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.
[30] M. Berna,et al. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers , 2007, Expert review of proteomics.
[31] S. Edge,et al. Downregulation of Gelsolin Correlates with the Progression to Breast Carcinoma , 2004, Breast Cancer Research and Treatment.
[32] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[33] Hoguen Kim,et al. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations , 2006, Proteomics.
[34] Darryl B. Hardie,et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.
[35] T. Shaler,et al. Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap. , 2006, Analytical chemistry.
[36] John R Yates,et al. Influence of basic residue content on fragment ion peak intensities in low-energy collision-induced dissociation spectra of peptides. , 2004, Analytical chemistry.
[37] Steven P Gygi,et al. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. , 2005, Methods.
[38] Nam-Soon Kim,et al. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. , 2006, International journal of oncology.
[39] Fagen Zhang,et al. Quantitation of human glutathione S-transferases in complex matrices by liquid chromatography/tandem mass spectrometry with signature peptides. , 2004, Rapid communications in mass spectrometry : RCM.
[40] S. Wisniewski,et al. Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment , 2003, Annals of neurology.
[41] William E Grizzle,et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[42] S. Goodison,et al. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. , 2007, Journal of proteome research.
[43] J. Mehta,et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. , 1996, American heart journal.
[44] Tasneem H. Patwa,et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. , 2008, Journal of proteome research.
[45] D. Chace. Mass spectrometry in the clinical laboratory. , 2001, Chemical reviews.
[46] E. Hawe,et al. Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[47] W. Demark-Wahnefried,et al. Zinc α-2-Glycoprotein Is Expressed by Malignant Prostatic Epithelium and May Serve as a Potential Serum Marker for Prostate Cancer , 2001 .
[48] P. Oeller,et al. Global proteome discovery using an online three-dimensional LC-MS/MS. , 2005, Journal of proteome research.
[49] S. Kingsmore. Multiplexed protein measurement: technologies and applications of protein and antibody arrays , 2006, Nature Reviews Drug Discovery.
[50] E Vuori,et al. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[51] G. Hall,et al. Proteomic Profiling Identifies Afamin as a Potential Biomarker for Ovarian Cancer , 2007, Clinical Cancer Research.
[52] Daniel B. Martin,et al. Computational prediction of proteotypic peptides for quantitative proteomics , 2007, Nature Biotechnology.
[53] George G Klee,et al. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry. , 2004, Journal of proteome research.